BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 23926069)

  • 1. Evolutionary pattern of reemerging influenza B/Victoria lineage viruses in São Paulo, Brazil, 1996-2012: Implications for vaccine composition strategy.
    Paiva TM; Benega MA; Silva DB; Santos KC; Cruz AS; Hortenci MF; Barbieri MT; Monteiro MM; Barbosa HA; Carvalhanas TR
    J Med Virol; 2013 Nov; 85(11):1983-9. PubMed ID: 23926069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the hemagglutinins and neuraminidases of human influenza B viruses isolated in Italy during the 2001-02, 2002-03, and 2003-04 seasons.
    Puzelli S; Frezza F; Fabiani C; Ansaldi F; Campitelli L; Lin YP; Gregory V; Bennett M; D'Agaro P; Campello C; Crovari P; Hay A; Donatelli I
    J Med Virol; 2004 Dec; 74(4):629-40. PubMed ID: 15484280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the demographic and clinical characteristics of laboratory-confirmed influenza B Yamagata and Victoria lineage infection.
    Sočan M; Prosenc K; Učakar V; Berginc N
    J Clin Virol; 2014 Sep; 61(1):156-60. PubMed ID: 25034374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reappearance of Victoria lineage influenza B virus in Brazil, antigenic and molecular analysis.
    Motta FC; Siqueira MM; Lugon AK; Straliotto SM; Fernandes SB; Krawczuk MM
    J Clin Virol; 2006 Jul; 36(3):208-14. PubMed ID: 16713335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological and virological assessment of influenza activity in Europe, during the 2004-2005 winter.
    Meijer A; Paget WJ; Meerhoff TJ; Brown CS; Meuwissen LE; van der Velden J;
    Euro Surveill; 2006; 11(5):111-8. PubMed ID: 16757850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages.
    Camilloni B; Neri M; Lepri E; Iorio AM
    Vaccine; 2009 Jun; 27(31):4099-103. PubMed ID: 19410623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology of influenza B virus and implications in immunization strategy, Southern Brazil.
    Lapinscki B; Pereira LA; Nogueira MB; Vidal LR; Riediger I; Debur MC; Presibella M; Raboni SM
    Vaccine; 2018 Jan; 36(1):107-113. PubMed ID: 29174679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons.
    Shaw MW; Xu X; Li Y; Normand S; Ueki RT; Kunimoto GY; Hall H; Klimov A; Cox NJ; Subbarao K
    Virology; 2002 Nov; 303(1):1-8. PubMed ID: 12482653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of influenza B viruses circulating in northern Italy during the 2001-2002 epidemic season.
    Ansaldi F; D'Agaro P; De Florentiis D; Puzelli S; Lin YP; Gregory V; Bennett M; Donatelli I; Gasparini R; Crovari P; Hay A; Campello C
    J Med Virol; 2003 Jul; 70(3):463-9. PubMed ID: 12767012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004-2017.
    Puzelli S; Di Martino A; Facchini M; Fabiani C; Calzoletti L; Di Mario G; Palmieri A; Affanni P; Camilloni B; Chironna M; D'Agaro P; Giannecchini S; Pariani E; Serra C; Rizzo C; Bella A; Donatelli I; Castrucci MR;
    BMC Infect Dis; 2019 Nov; 19(1):990. PubMed ID: 31752738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of influenza B lineages from 2001 to 2013 in a tertiary hospital in the city of São Paulo, Brazil.
    Perosa AH; Granato C; Bellei N
    Mem Inst Oswaldo Cruz; 2015 Aug; 110(5):606-10. PubMed ID: 26132429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of isolates from influenza B outbreaks in the U.S. and Nepal, 2005.
    Daum LT; Canas LC; Klimov AI; Shaw MW; Gibbons RV; Shrestha SK; Myint KS; Acharya RP; Rimal N; Reese F; Niemeyer DM; Arulanandam BP; Chambers JP
    Arch Virol; 2006 Sep; 151(9):1863-74. PubMed ID: 16736092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quadrivalent Ann Arbor strain live-attenuated influenza vaccine.
    Toback SL; Levin MJ; Block SL; Belshe RB; Ambrose CS; Falloon J
    Expert Rev Vaccines; 2012 Nov; 11(11):1293-303. PubMed ID: 23151111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential age susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian influenza season.
    Barr IG; Vijaykrishna D; Sullivan SG
    Euro Surveill; 2016; 21(4):. PubMed ID: 26848118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.
    Janjua NZ; Skowronski DM; De Serres G; Dickinson J; Crowcroft NS; Taylor M; Winter AL; Hottes TS; Fonseca K; Charest H; Drews SJ; Sabaiduc S; Bastien N; Li Y; Gardy JL; Petric M
    J Infect Dis; 2012 Jun; 205(12):1858-68. PubMed ID: 22492921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing appearance of reassortant influenza B virus in Taiwan from 2002 to 2005.
    Tsai HP; Wang HC; Kiang D; Huang SW; Kuo PH; Liu CC; Su IJ; Wang JR
    J Clin Microbiol; 2006 Aug; 44(8):2705-13. PubMed ID: 16891481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza B lineage circulation and hospitalization rates in a subtropical city, Hong Kong, 2000-2010.
    Chan PK; Chan MC; Cheung JL; Lee N; Leung TF; Yeung AC; Wong MC; Ngai KL; Nelson EA; Hui DS
    Clin Infect Dis; 2013 Mar; 56(5):677-84. PubMed ID: 23074315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.